Hurley R W, Grabow T S, Tallarida R J, Hammond D L
Committee on Neurobiology, University of Chicago, Chicago, Illinois, USA.
J Pharmacol Exp Ther. 1999 May;289(2):993-9.
Previous work supports the existence of two types of delta opioid receptor (delta1 and delta2) and a role of both subtypes in the spinal cord and the ventromedial medulla (VMM) in the production of antinociception. Although it is well established that spinal and supraspinal mu opioid receptors interact in a synergistic manner to produce antinociception, little is known about the interaction of delta opioid receptors. This study used isobolographic analysis to determine how delta1 and delta2 opioid receptors in the VMM interact with their respective receptors in the spinal cord to produce antinociception. Concurrent administration of the delta1 opioid receptor agonist [D-Pen2,D-Pen5]enkephalin at spinal and supraspinal sites in a fixed-dose ratio produced antinociception in an additive manner in the tail-flick test. In contrast, concurrent administration of very low doses of the delta2 opioid receptor agonist [D-Ala2,Glu4]deltorphin at spinal and medullary sites produced antinociception in a synergistic manner. However, as the total dose of [D-Ala2,Glu4]deltorphin increased, this interaction converted to additivity. These observations suggest that different mechanisms mediate the antinociceptive effects of different doses of delta2 opioid receptor agonists. The difference in the nature of the interaction produced by delta1 and delta2 opioid receptor agonists provides additional evidence for the existence of different subtypes of the delta opioid receptor. These results also suggest that delta2 opioid receptor agonists capable of crossing the blood-brain barrier will be more potent or efficacious analgesics than delta1 opioid receptor agonists after systemic administration.
先前的研究支持存在两种类型的δ阿片受体(δ1和δ2),且这两种亚型在脊髓和延髓腹内侧(VMM)产生抗伤害感受的过程中均发挥作用。尽管脊髓和脊髓上的μ阿片受体以协同方式相互作用以产生抗伤害感受已得到充分证实,但关于δ阿片受体之间的相互作用却知之甚少。本研究采用等效线图分析法来确定VMM中的δ1和δ2阿片受体如何与其在脊髓中的各自受体相互作用以产生抗伤害感受。以固定剂量比例在脊髓和脊髓上部位同时给予δ1阿片受体激动剂[D-青霉胺2,D-青霉胺5]脑啡肽,在甩尾试验中以相加方式产生抗伤害感受。相比之下,在脊髓和延髓部位同时给予极低剂量的δ2阿片受体激动剂[D-丙氨酸2,谷氨酸4]强啡肽则以协同方式产生抗伤害感受。然而,随着[D-丙氨酸2,谷氨酸4]强啡肽总剂量的增加,这种相互作用转变为相加作用。这些观察结果表明,不同机制介导了不同剂量的δ2阿片受体激动剂的抗伤害感受作用。δ1和δ2阿片受体激动剂产生的相互作用性质的差异为δ阿片受体存在不同亚型提供了额外证据。这些结果还表明,能够穿过血脑屏障的δ2阿片受体激动剂在全身给药后将比δ1阿片受体激动剂更有效或更高效地发挥镇痛作用。